outcome regardless of whether a woman has DM. In the adjusted model, labor (compared to no labor) was associated with a lower odds of composite neonatal respiratory morbidity at 36 weeks (aOR 0.60, CI 0.44-0.83), 37 weeks (0.43, CI 0.33-0.56), 38 weeks (aOR 0.51, CI 0.39-0.66), 39-40 weeks (aOR 0.70, CI 0.60-0.82) (Figure 1 ). This difference was driven by lower frequencies of RDS and CPAP in the labor group, with no difference in the need for ventilator support between groups. CONCLUSION: p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Arial} Labor was associated with improved respiratory outcomes for neonates delivered from 36 through 40 weeks gestation with the magnitude of this association varying by gestational age. This association was similar for women with and without DM.
OBJECTIVE:
To compare pregnancy outcome in extremely advanced maternal age of >50 years to that of women aged 45-50 years at delivery.
STUDY DESIGN:
A retrospective cohort study in a single tertiary center of all women of extremely advanced maternal age of 45 years and above, who delivered at our center between 2011-2018. Women were excluded if delivered prior to 22 weeks of gestation. The maternal and neonatal outcomes of women >50 years of age at delivery (n¼55) were compared to those of women aged 45-50 years (n¼299). Subgroup analysis was performed for multiple gestations in these age groups. RESULTS: Baseline pre-conceptional maternal characteristics and chronic diseases in women>50 were comparable to those of 45-49 years. Women>50 years of age were at a significantly higher risk of hypertensive disorders in general, and severe hypertensive diseases (pre-eclampsia with severe features, HELLP syndrome and eclampsia) than women of 45-49 years of age (29.1% vs 17.4%, p¼0.04 and 20.0% vs. 8.7%, p¼0.02, respectively). Cesarean delivery rate exceeded 75% in both age groups but was significantly higher in women >50 (89.1% vs 75.3%, respectively p¼0.02).
Subanalysis of multiple gestations demonstrated an exceptionally high rate of prematurity <34 weeks of gestation in women >50 years (52.9% vs 21.1%, p¼.004), and consequently composite outcomes of severe neonatal morbidity (intraventricular hemorrhage, necrotizing enterocolitis, asphyxia) and ventilatory support rates were higher as well (17.6% vs 3.5%, p¼0.01 and 29.4% vs 4.2%, p<.001, respectively). CONCLUSION: Pregnancy beyond the age of fifty is associated with increased maternal and neonatal morbidity, beyond that of women aged 45-50. Multiple pregnancy in women over 50 exposes their neonates to extremely high morbidity.
Oral Concurrent 6 CLINICAL OB 1 ajog.org OBJECTIVE: Nifedipine is frequently used for acute tocolysis of preterm labor, despite there being no reports of its effectiveness compared to placebo. We sought to compare the effectiveness of nifedipine to placebo. STUDY DESIGN: We conducted a randomized, double-blind, placebocontrolled trial of nifedipine. Women ages 16-44 who had documented uterine activity and who were at risk of preterm birth were included if they had a singleton pregnancy with intact membranes between 28-0/7 and 33-6/7 weeks' gestation and cervical dilatation between 2 and 4 cm. Women who consented to participate were randomized and received nifedipine 20 mg or placebo orally, then nifedipine 20 mg or placebo orally after 90 minutes if still contracting. Nifedipine 20 mg or placebo was continued orally every 4 hours after the first dose, for 48 hours. RESULTS: The protocol specified that a total of 150 patients be included, but after a pre-planned interim analysis, the Data Safety Monitoring Committee recommended discontinuation of the trial due to futility. The study was terminated after randomization of a total of 88 subjects with data available for analysis: 46 for nifedipine and 42 for placebo. Nifedipine did not affect blood pressure in normotensive women, but heart rates were significantly increased after the first 4 hours and at the end of the 48-hour window. Despite this physiologic effect, there were no statistically significant differences in the primary or prespecified secondary outcomes (Table) . The rate of discontinuation for side effects did not differ. There were no stillbirths and no significant differences in neonatal outcomes. CONCLUSION: Acute tocolysis of preterm labor with nifedipine did not affect preterm birth rates, with the interim analysis demonstrating futility for study continuation.
74 Delivery mode and future infectious morbidity of the offspring e a sibling analysis OBJECTIVE: Cesarean delivery (CD) has been shown to affect the newborn's microbiome, and was recently suggested to be associated with several long-term health implications in offspring. We aimed to investigate the association between delivery mode and long-term infectious morbidity of the offspring while employing sibling analysis theme in order to maximize confounder control. STUDY DESIGN: A prospectively analyzed population-based cohort study was performed, which included all sibling deliveries occurring between 1991 and 2014 at a regional tertiary medical center. The study included 13,516 individuals (6758 siblings pairs): the first born was via vaginal delivery (VD) and the second via CD. Each siblings pair was considered a matched set, with the aim to perform a withinfamily analysis. CD was considered the exposure, and VD the comparison. The risk for long-term infectious morbidity in offspring was based on the hospital's pediatric database and a pre-defined set of infectious ICD-9 code list associated with offspring hospitalizations. Only the first infectious related hospitalization for each child up to the age of 18 years was included. A KaplaneMeier survival curve was used to compare the cumulative infectious morbidity incidence and a Cox hazards models to control for confounders. RESULTS: Crude rates of total infectious hospitalizations were found to be significantly higher in the CD group (OR¼1.2; 95%CI, 1.12-1.4, p<0.001). Specifically, bronchiolitis (OR¼2.0, 95%CI 1.5-2.6, p<0.001), otitis (OR¼1.5, 95%CI 1.2-1.9, p<0.001), respiratory syncytial virus (OR¼4.3, 95%CI 1.2-15.2, p¼0.021) and gastroenteritis (OR¼1.4, 95%CI 1.1-1.9, p¼0.025; Table) were all found to be significantly more common in the CD group. The survival curve demonstrated significantly higher cumulative infectious related hospitalization rates in the CD group (log rank p<0.001; Figure) . The Cox model, adjusted for maternal age, birthweight, preeclampsia, diabetes, smoking, induction of labor, and obesity, confirmed the significant association between CD and later offspring infectious related morbidity (adjusted HR¼ 1.2; 95%CI 1.1-1.4, p¼0.027). CONCLUSION: CD appears to be independently associated with later offspring infectious related morbidity, even while rigorously adjusting for confounders. Physicians should consider potential
